Glenmark Pharma slashes price of breast cancer drug Trastuzumab

Trastuzumab is used in the treatment of a particular type of breast cancer -- HER2-positive, and the company markets its version in India under the brand name 'Trumab'. It is now priced at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier.